Published on:
    Journal of Cardiovascular Disease Research, 2011; 2(2):133-136
    CLINICAL CASE REPORT BASED STUDY | doi:10.4103/0975-3583.83037

    Evaluation of the autologous bone marrow mononuclear therapy and functional restoration in the scarred myocardium by imaging analysis

    Authors:

    Alla Gopala Krishna Gokhale,Lakshmi Kiran Chelluri1, K. Kumaresan2, G. Subramanyam3, K. Sudhakar3, Sathish Vemuri1,Tanya Debnath1, K. S. Ratnakar4

    Department of Cardiothoracic Surgery,

    1Department of Transplant Biology and Stem Cell Lab,

    2Department of Nuclear Medicine, KK Nuclear Scans Clinic, Somajiguda, Hyderabad -500 004, India.

    3Department of Anesthesiology,

    4Department of Pathology, Global Hospitals, Lakdi-ka-Pool.

    Abstract:

    A 62-year-old male patient with previous history of myocardial infarction, akinetic myocardial segments, and an ejection fraction of 31% with the NYHA class III category was selected for the autologous bone marrow (ABM)-derived mononclear cell fraction during CABG surgery. Nitrate augmented myocardial tracer uptake was imaged by ECG gated SPECT pre-and 1 year post-ABM therapy, using radiotracer Tc99m Sestamibi. The baseline gated SPECT demonstrated full thickness infarct 40% area of LAD territory. Bone marrow aspirate of 20.0 ml of sterline mormal saline yielding a mono nuclear cell fraction of 4.5x107 cells/ml was suspended in 2.0ml of sterile normal saline to be injected at eight sites of the injured myocardium. There were no apparent side effects due to the procedure,i.e., life threatening events,major bleeds, reaction, or shock.The case was followed at the end of 1,3,6 months by ECG and monitor and ECG gated SPECT at the end of 12 months. The gated SPECT image demonstrated mild but definitely improved tracer uptake within part of the infracted segments along with improvement in ejection fraction to 45%, and a clinical change in the NYHA Class to II. Cell-based therapy may offer benefits of induction of normal tissue microenvironment.

    Key words: Autologous bone marrow mononuclear therapy, cardiovascular disease research,myocardial infraction, molecular imaging.